Abstract

Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension

Author(s): Allen Loyd V Jr

Issue: May/Jun 2018 - Volume 22, Number 3

Page(s): 235

Download in electronic PDF format for $75
  • Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Page 1

Abstract

A formulation for preparing Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • gabapentin
  • seizures
  • neuropathic pain
  • nerve pain
  • shingles
  • anticonvulsant

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2018
Pg. 235
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 505
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 486
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 415
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 416
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 44
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 47
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2022
Pg. 65-71
Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Author(s): Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
Nov/Dec 2006
Pg. 456
Gabapentin 100-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 200-203
Topical Medications for Orofacial Neuropathic Pain
Author(s): Bramwell Bethany L
Jan/Feb 2018
Pg. 54
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 496-503
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Author(s): Shakshuki Ayah, Agu Remigius U
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Sep/Oct 2024
Pg. 408-412
Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF
Author(s): Friciu Mihaela, Cull Erica, Leclair Grégoire
May/Jun 2010
Pg. 215-217
Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report
Author(s): Muller George
Nov/Dec 2017
Pg. 494
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr